LV15003A - Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei - Google Patents

Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei

Info

Publication number
LV15003A
LV15003A LVP-13-157A LV130157A LV15003A LV 15003 A LV15003 A LV 15003A LV 130157 A LV130157 A LV 130157A LV 15003 A LV15003 A LV 15003A
Authority
LV
Latvia
Prior art keywords
control
pharmaceutical composition
weight gain
phenotropil
phenylpyrrolidin
Prior art date
Application number
LVP-13-157A
Other languages
English (en)
Other versions
LV15003B (lv
Inventor
Ivars KALVIŅŠ
Līga ZVEJNIECE
Maija Dambrova
Baiba ŠVALBE
Edgars LIEPIŅŠ
Antons ĻEBEDEVS
Aleksandrs ČERNOBROVIJS
Larisa Varačeva
Original Assignee
Latvijas Organiskās Sintēzes Institūts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Latvijas Organiskās Sintēzes Institūts filed Critical Latvijas Organiskās Sintēzes Institūts
Priority to LVP-13-157A priority Critical patent/LV15003B/lv
Priority to US15/028,794 priority patent/US20160250185A1/en
Priority to DE112014004843.7T priority patent/DE112014004843T5/de
Priority to PCT/LV2014/000011 priority patent/WO2015060702A1/en
Priority to CA2918741A priority patent/CA2918741A1/en
Publication of LV15003A publication Critical patent/LV15003A/lv
Publication of LV15003B publication Critical patent/LV15003B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Izgudrojums attiecas uz medicīnu, konkrēti uz S-fenotropilu ((S)-2-(2-okso-4-fenilpirolidin-1-il)acetamīdu) saturošām farmaceitiskām kompozīcijām un to pielietošanu ķermeņa masas pieauguma kontrolei.
LVP-13-157A 2013-10-22 2013-10-22 Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei LV15003B (lv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
LVP-13-157A LV15003B (lv) 2013-10-22 2013-10-22 Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei
US15/028,794 US20160250185A1 (en) 2013-10-22 2014-10-20 Pharmaceutical composition for controlling body mass gain comprising s-phenotropil
DE112014004843.7T DE112014004843T5 (de) 2013-10-22 2014-10-20 Pharmazeutische Zusammensetzung zur Kontrolle der Zunahme von Körpermasse mit S-Phenotropil
PCT/LV2014/000011 WO2015060702A1 (en) 2013-10-22 2014-10-20 Pharmaceutical composition for controlling body mass gain comprising s-phenotropil
CA2918741A CA2918741A1 (en) 2013-10-22 2014-10-20 Pharmaceutical composition for controlling body mass gain comprising s-phenotropil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-13-157A LV15003B (lv) 2013-10-22 2013-10-22 Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei

Publications (2)

Publication Number Publication Date
LV15003A true LV15003A (lv) 2015-05-20
LV15003B LV15003B (lv) 2015-08-20

Family

ID=51947418

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-13-157A LV15003B (lv) 2013-10-22 2013-10-22 Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei

Country Status (5)

Country Link
US (1) US20160250185A1 (lv)
CA (1) CA2918741A1 (lv)
DE (1) DE112014004843T5 (lv)
LV (1) LV15003B (lv)
WO (1) WO2015060702A1 (lv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2732245C1 (ru) * 2019-08-30 2020-09-14 Ооо "Валента-Интеллект" Новые составы n-карбамоилметил-4-фенил-2-пирролидона для лечения и профилактики ожирения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV13630B (en) * 2006-03-16 2007-12-20 Olainfarm As Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone
AU2009219050B2 (en) * 2008-02-29 2014-04-24 Biolab Sanus Farmaceutica Ltda. Pharmaceutical composition comprising racetam and carnitine and process for its preparation
RU2480214C1 (ru) * 2011-09-22 2013-04-27 Валентина Ивановна Ахапкина Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов

Also Published As

Publication number Publication date
US20160250185A1 (en) 2016-09-01
DE112014004843T5 (de) 2016-07-07
CA2918741A1 (en) 2015-04-30
LV15003B (lv) 2015-08-20
WO2015060702A1 (en) 2015-04-30
WO2015060702A8 (en) 2016-07-07

Similar Documents

Publication Publication Date Title
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MY187540A (en) Compounds active towards bromodomains
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
PH12015502615B1 (en) Chemical compounds
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
TN2015000278A1 (en) Autotaxin inhibitors
PH12015501648B1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
MX2015009106A (es) Composiciones de solución sólida y su uso en el tratamiento del dolor intenso.
PH12016501122A1 (en) Delayed release compositions of linaclotide
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
IN2015DN03327A (lv)
PH12015501096A1 (en) Composition for immediate and extended release
MX355831B (es) NOVEDOSOS HIDRATOS CRISTALINOS DE 1-(ß-D-GLUCOPIRANOSIL)-4-METIL-3 -[5-(4-FLUORO-FENIL)-2-TIENIL-METIL]-BENCENO.
EP3187189A4 (en) Composition and medicinal product for reducing body weight and body fat, and use of said product
HK1211021A1 (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions 2--6--9--9h-
MX2015008021A (es) Composiciones y metodos para administracion transdermica de hormonas y otros agentes medicos.
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
EA032927B1 (ru) Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора
SG11201605868XA (en) Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
MX366829B (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
EP2978421A4 (en) STABLE NANOCOMPOSITION COMPRISING DOCATEXEL, PROCESS FOR PREPARATION THEREOF, USE THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MX2015009891A (es) Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion.
LV15003A (lv) Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei